MARCHF4 and prostate carcinoma: Moreover, MARCHF4, a membrane associated E3 ubiquitin ligase from the MARCH family, has previously been shown in prostate cancer cells to enhance survival under chemotherapeutic stress, promote an epithelial mesenchymal transition phenotype, and mitigate chemotherapy induced apoptosis (91).